Pramipexole
پرامیپکسول
🧠 Nervous SystemDopamine agonist
Market / country: 🇺🇸 USA
Mirapex (US) · Sifrol (GB)
🧮 Dose calculator
Restless legs syndrome · Regimen source: FDA Pramipexole · 2.3
- • If needed every 4–7 days: 0.25 then 0.5 mg (CrCl 20–60: every 14 days). FDA Pramipexole · 2.3
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Warnings
- • Falling asleep during activities; impulse-control behaviours (gambling, shopping, sexual urges); orthostatic hypotension. FDA Pramipexole · 5
Formulations
- 0.125 mg tablet — tablet 🇺🇸 USA FDA Pramipexole · 3
- 0.25 mg tablet — tablet 🇺🇸 USA FDA Pramipexole · 3
- 0.5 mg tablet — tablet 🇺🇸 USA FDA Pramipexole · 3
- 1 mg tablet — tablet 🇺🇸 USA FDA Pramipexole · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Pramipexole · 8.1
“Risk Summary There are no adequate data on the developmental risk associated with the use of pramipexole dihydrochloride tablets in pregnant women.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Pramipexole · 8.2
“Risk Summary There are no data on the presence of pramipexole in human milk, the effects of pramipexole on the breastfed infant, or the effects of pramipexole on milk production.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Pramipexole · 8.4
“Safety and effectiveness of pramipexole dihydrochloride tablet in pediatric patients has not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Pramipexole · 8.5
“Pramipexole total oral clearance is approximately 30% lower in subjects older than 65 years compared with younger subjects, because of a decline in pramipexole renal clearance due to an age-related reduction in renal function.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA202702
- DailyMed (FDA label)FDA Pramipexole
- MedlinePlus (NIH)Pramipexole
- WHO ATC/DDDN04BC05
- Darooyab (Iran)Pramipexole
🇮🇷 Registered in Iran Darooyab · G-2496/Pramipexole
Dosage forms with Iranian generic codes, per Darooyab.
- 09238 · PRAMIPEXOLE 0.088MG TAB · قرص پرامیپکسول ۰٫۰۸۸ میلیگرم
- 06049 · PRAMIPEXOLE 0.18MG TAB · قرص پرامیپکسول ۰٫۱۸ میلیگرم
- 05450 · PRAMIPEXOLE 0.25MG TAB · قرص پرامیپکسول ۰٫۲۵ میلیگرم
- 10019 · PRAMIPEXOLE 0.35MG TAB · قرص پرامیپکسول ۰٫۳۵ میلیگرم
- 17837 · PRAMIPEXOLE 0.375MG ER TAB · قرص آهستهرهش پرامیپکسول ۰٫۳۷۵ میلیگرم
- 17836 · PRAMIPEXOLE 0.75MG ER TAB · قرص آهستهرهش پرامیپکسول ۰٫۷۵ میلیگرم
- 06050 · PRAMIPEXOLE 0.7MG TAB · قرص پرامیپکسول ۰٫۷ میلیگرم
- 17838 · PRAMIPEXOLE 1.5MG ER TAB · قرص آهستهرهش پرامیپکسول ۱٫۵ میلیگرم
- 06790 · PRAMIPEXOLE 1MG TAB · قرص پرامیپکسول ۱ میلیگرم
- 50993 · PRAMIPEXOLE (AS DIHYDROCHLORIDE) TABLET, EXTENDED RELEASE ORAL 2.1 mg · قرص آهستهرهش پرامیپکسول (معادل دیهیدروکلراید) ۲٫۱ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Pramipexole · 3FDA Pramipexole · 2.3FDA Pramipexole · 2.2FDA Pramipexole · 2FDA Pramipexole · 5FDA Pramipexole · 8.1FDA Pramipexole · 8.2FDA Pramipexole · 8.4FDA Pramipexole · 8.5FDA Pramipexole · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2496/Pramipexole
- Clinical review⚠ Unverified